Maraviroc,,Active Pharmaceutical Ingredients,Other Active Pharmaceutical Ingredients
Is Manufacturer
No
Product Description
Name Maraviroc
Synonym 4,4-Difluoro-N-[(1S)-3-[(1R,5S)-3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]cyclohexane-1-carboxamide
Catalog # AP4800
CAS # 376348-65-1
Molecular Formula C
AI Product Description
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Maraviroc is a CCR5 antagonist used in <strong>HIV-1 treatment</strong>. Synthesized via chiral catalysis, its molecular formula is <strong>C<sub>27</sub>H<sub>30</sub>N<sub>4</sub>O<sub>4</sub></strong> with CAS No. <strong>376625-83-9</strong>.</p>
<h3>Application</h3>
<ul>
<li><strong>Pharmaceutical Manufacturing:</strong> Active ingredient for fixed-dose combination antiretrovirals.</li>
<li><strong>Clinical Therapy:</strong> Treatment of CCR5-tropic HIV-1 infection in drug-experienced patients.</li>
<li><strong>Research:</strong> Tool compound for studying chemokine receptor biology.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly contraindicated for CXCR4 or dual/mixed tropic viruses. Store at controlled room temperature (20°C to 25°C) in dry conditions. Monitor liver function and hypersensitivity reactions during therapy.</p>